Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma

por She, Longjiang, Tian, Kun, Han, Jiaqi, Zuo, Weihan, Wang, Zhu, Zhang, Ning
Publicado 2022

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

por Hu, Huabin, She, Longjiang, Liao, Mengting, Shi, Yin, Yao, Linli, Ding, Dong, Zhu, Youwen, Zeng, Shan, Carbone, David P., Huang, Jin
Publicado 2020

Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcin...

por Tang, Siqi, Wu, Zhenyu, Chen, Lusi, She, Longjiang, Zuo, Weihan, Luo, Weijun, Zhang, Yang, Liang, Shaoqiang, Liu, Guichao, He, Biyi, He, Jinfeng, Zhang, Ning
Publicado 2023

Cost-Effectiveness Analysis of First-Line FOLFIRI Combined With Cetuximab or Bevacizumab in Patients With RAS Wild-Type Left-Sided Metastatic Colorectal Cancer

por Han, Jiaqi, Xiao, Desheng, Tan, Chongqing, Zeng, Xiaohui, Hu, Huabin, Zeng, Shan, Jiang, Qin, She, Longjiang, Yao, Linli, Li, Li, Tang, Lanhua, Ma, Jian, Huang, Jin, Shen, Liangfang
Publicado 2020